Many companies.
One thesis.
The companies we've originated, built, and capitalized; each one tackling a category where the standard of care is overdue for a redesign.
Reimagining urinary incontinence at the source
1 in 2 women live with urinary incontinence, yet fewer than 1 in 3 ever seek treatment. Genevi treats the true cause, not just the symptom.
Decades of research point to a single root cause of urinary incontinence: weakening of the urethral sphincter. Today's options (pads, Kegels, drugs, and surgery) largely manage symptoms rather than restoring the muscle that keeps a woman continent. Genevi is built to change that.
Genevi's platform pairs a tampon-sized therapeutic insert with a guided, at-home program that delivers targeted neuromuscular stimulation directly to the urethra: rebuilding closure strength over an eight-week course. The work is grounded in a long-running partnership with the University of Michigan Pelvic Floor Research Group, one of the world's leading centers for pelvic biomechanics.
A clinically supported approach to accidental bowel leakage
Accidental bowel leakage affects 9% of women, yet treatment options remain limited and invasive. TOPAS is a minimally invasive sling, proven in clinical study and ready to scale.
TOPAS is a minimally invasive posterior anal sling for accidental bowel leakage — a debilitating, under-recognized and under-treated condition affecting millions of women. Placed in a sub-30-minute outpatient procedure, the sling restores support without the complications of legacy surgical approaches.
The technology is already clinically de-risked: supported by multiple clinical studies with strong long-term safety, efficacy, and quality-of-life outcomes.
Closing the gap in preterm birth prevention
For at-risk pregnancies, the standard of care is still an invasive 1950s surgical procedure. MaternalSure brings that protection into the office — without a stitch.
Cervical insufficiency is a leading, preventable driver of preterm birth, yet the gold-standard response — surgical cerclage — requires an operating room, general anesthesia, and a specialist who simply isn't available in most U.S. counties. As a result, the vast majority of at-risk women are left behind by today's standard of care.
MaternalSure is developing a office-based, minimally invasive alternative built for today's OB: cervical support placed without a stitch, no operating room, and no general anesthesia. Designed by a maternal-fetal medicine specialist, MaternalSure is engineered to extend specialist-level care to all at risk pregnancies.
More in development
We never stop looking for new ways to redefine the standard of care. Several stealth companies are already in the works, with more news coming soon.
Get in touch →